Moreover, AAV-sh-Elk1 treatment depressed IL-17 and IL-6 expression in lung tissues of ARDS rats, which was negated by AAV-sh-Fcgr2b treatment (Fig. 6E). This evidence concerns the gene IL17A and acute respiratory distress syndrome.